Paeoniflorin has been found to regulate the biological characteristics of tumors through multiple targets [27, 28], and although the direct target of paeoniflorin has not been discovered yet, our data revealed that SIRT4 is a critical protein in the mechanism that paeoniflorin enhances the sensitivity of ER + breast cancer cells to tamoxifen. Here, ESR1 is linked to breast carcinoma.